The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Being overweight, having diabetes, alcohol use, and chronic viral hepatitis have also been associated with progressive fibrosis in methotrexate‐treated patients.51,52”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Miele, L., Vallone, S., Cefalo, C., La Torre, G., Di Stasi, C., Vecchio, F. M., D’Agostino, M., Gabrieli, M. L., Vero, V., Biolato, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.008 · Cited by 249 · cited 2×
“Guidelines for monitoring methotrexate liver toxicity should be revisited and harmonized [46,47] focusing on the other risk factors for liver fibrosis such as high alcohol consumption or metabolic syndrome [35].”
BackgroundAbnormal hepatic biochemistries in patients with inflammatory bowel disease
Mendes, F. D., Levy, C., Enders, F. B., Loftus, E. V., Angulo, P., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00947.x · Cited by 147
Research works printed but not linked: 44
- Kremer, 1986, The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis, Arthritis Rheum, 29, 822, 10.1002/art.1780290702 · DOI · Paper page
- Laharie, 2008, The liver and methotrexate, Gastroenterol Clin Biol, 32, 134, 10.1016/j.gcb.2007.11.002 · doi:10.1016/j.gcb.2007.11.002
- Lanse, 1985, Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio, Dig Dis Sci, 30, 104, 10.1007/BF01308193 · doi:10.1007/bf01308193
- Te, 2000, Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease, Am J Gastroenterol, 95, 3150, 10.1111/j.1572-0241.2000.03287.x · doi:10.1111/j.1572-0241.2000.03287.x
- Kremer, 1994, Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology, Arthritis Rheum, 37, 316, 10.1002/art.1780370304 · DOI · Paper page
- Chande, 2005, A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn’s disease, Can J Gastroenterol, 19, 553, 10.1155/2005/382379 · doi:10.1155/2005/382379
- Kalb, 2009, Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference, J Am Acad Dermatol, 60, 824, 10.1016/j.jaad.2008.11.906 · DOI · Paper page
- Cadranel, 2000, Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF), Hepatology, 32, 477, 10.1053/jhep.2000.16602 · DOI · Paper page
- Bravo, 2001, Liver biopsy, N Engl J Med, 344, 495, 10.1056/NEJM200102153440706 · DOI · Paper page
- Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, 38, 1449, 10.1016/j.hep.2003.09.022 · DOI · Paper page
- Colloredo, 2003, Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease, J Hepatol, 39, 239, 10.1016/S0168-8278(03)00191-0 · DOI · Paper page
- Maharaj, 1986, Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver, Lancet, 1, 523, 10.1016/S0140-6736(86)90883-4 · DOI · Paper page
- Halfon, 2008, FibroTest-ActiTest as a non-invasive marker of liver fibrosis, Gastroenterol Clin Biol, 32, 22, 10.1016/S0399-8320(08)73991-5 · DOI
- de Ledinghen, 2008, Transient elastography (FibroScan), Gastroenterol Clin Biol, 32, 58, 10.1016/S0399-8320(08)73994-0 · DOI · Paper page
- de Ledinghen, 2006, Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients, J Acquir Immune Defic Syndr, 41, 175, 10.1097/01.qai.0000194238.15831.c7 · DOI · Paper page
- Marcellin, 2009, Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B, Liver Int, 29, 242, 10.1111/j.1478-3231.2008.01802.x · DOI · Paper page
- Ziol, 2005, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C, Hepatology, 41, 48, 10.1002/hep.20506 · DOI · Paper page
- Laharie, 2006, Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn’s disease patients treated with methotrexate, Aliment Pharmacol Ther, 23, 1621, 10.1111/j.1365-2036.2006.02929.x · DOI
- Berends, 2007, Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: FibroTest predicts the presence and FibroScan predicts the absence of significant liver fibrosis, Liver Int, 27, 639, 10.1111/j.1478-3231.2007.01489.x · DOI
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497. · DOI · Paper page
- Imbert-Bismut, 2001, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, 357, 1069, 10.1016/S0140-6736(00)04258-6 · DOI · Paper page
- Fleming, 2008, Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: a general population-based study, J Hepatol, 49, 732, 10.1016/j.jhep.2008.05.023 · DOI · Paper page
- Fisher, 2009, Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity, J Rheumatol, 36, 539, 10.3899/jrheum.080576 · DOI
- Zachariae, 2000, Liver biopsies and methotrexate: a time for reconsideration?, J Am Acad Dermatol, 42, 531, 10.1016/S0190-9622(00)90237-8 · DOI
- Robinson, 1980, Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals, Arch Dermatol, 116, 413, 10.1001/archderm.1980.01640280049016 · DOI
- Newman, 1989, The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment, Arch Dermatol, 125, 1218, 10.1001/archderm.1989.01670210056007 · DOI
- Roenigk, 1998, Methotrexate in psoriasis: consensus conference, J Am Acad Dermatol, 38, 478, 10.1016/S0190-9622(98)70508-0 · DOI · Paper page
- Aithal, 2004, Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?, Aliment Pharmacol Ther, 19, 391, 10.1046/j.1365-2036.2004.01819.x · DOI
- Pavy, 2006, Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion, Joint Bone Spine, 73, 388, 10.1016/j.jbspin.2006.01.007 · doi:10.1016/j.jbspin.2006.01.007
- Lambert, 2004, Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial, Arthritis Rheum, 50, 364, 10.1002/art.20167 · doi:10.1002/art.20167
- Bridges, 1989, Methotrexate-induced liver abnormalities in rheumatoid arthritis, J Rheumatol, 16, 1180
- Whiting-O’Keefe, 1991, Methotrexate and histologic hepatic abnormalities: a meta-analysis, Am J Med, 90, 711, 10.1016/S0002-9343(05)80060-9 · DOI · Paper page
- Herron, 2005, Impact of obesity and smoking on psoriasis presentation and management, Arch Dermatol, 141, 1527, 10.1001/archderm.141.12.1527 · DOI · Paper page
- Gisondi, 2009, Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis, J Hepatol, 51, 758, 10.1016/j.jhep.2009.04.020 · DOI · Paper page
- Rosenberg, 2007, Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment, J Hepatol, 46, 1111, 10.1016/j.jhep.2007.01.024 · DOI · Paper page
- Regev, 2002, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol, 97, 2614, 10.1111/j.1572-0241.2002.06038.x · doi:10.1111/j.1572-0241.2002.06038.x · Paper page
- Siddique, 2003, Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection, Scand J Gastroenterol, 38, 427, 10.1080/00365520310000825 · DOI · Paper page
- Poynard, 2007, Meta-analyses of FibroTest diagnostic value in chronic liver disease, BMC Gastroenterol, 7, 40, 10.1186/1471-230X-7-40 · DOI · Paper page
- Amital, 2009, Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate, Rheumatology, 48, 1107, 10.1093/rheumatology/kep176 · doi:10.1093/rheumatology/kep176
- Wahed, 2009, Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine/mercaptopurine, Aliment Pharmacol Ther, 30, 614, 10.1111/j.1365-2036.2009.04073.x · DOI
- Van Dooren-Greebe, 1994, Methotrexate revisited: effects of long-term treatment in psoriasis, Br J Dermatol, 130, 204, 10.1111/j.1365-2133.1994.tb02901.x · doi:10.1111/j.1365-2133.1994.tb02901.x
- van Ede, 2001, Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study, Arthritis Rheum, 44, 1515, 10.1002/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7 · DOI · Paper page
- Lindsay, 2009, Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy, Rheumatology (Oxford), 48, 569, 10.1093/rheumatology/kep023 · DOI
- Visser, 2009, Ann Rheum Dis, 68, 1086, 10.1136/ard.2008.094474 · DOI · Paper page
Cited by
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Case definition and phenotype standardization in drug-induced liver injury
Aithal, G. P., Watkins, P. B., Andrade, R. J., Larrey, D., Molokhia, M., Takikawa, H., Hunt, C. M., Wilke, R. A., Avigan, M., Kaplowitz, N., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.58 · Cited by 944
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Collagen-targeted molecular imaging in diffuse liver diseases
Zhou, I. Y., Tanabe, K. K., Fuchs, B. C., & Caravan, P. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02677-2 · Cited by 14
Metadata
- Authors
- Laharie, D., Seneschal, J., Schaeverbeke, T., Doutre, M.-S., Longy-Boursier, M., Pellegrin, J.-L., Chabrun, E., Villars, S., Zerbib, F., & de Lédinghen, V.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 53
- Issue
- 6
- Pages
- 1035-1040
- ISSN
- 0168-8278
- Cited by
- 92
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study. https://app.cochat.ai/papers/10.1016/j.jhep.2010.04.043
- The paper
- Laharie, D., Seneschal, J., Schaeverbeke, T., Doutre, M.-S., Longy-Boursier, M., Pellegrin, J.-L., Chabrun, E., Villars, S., Zerbib, F., & de Lédinghen, V. (2010). Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2010.04.043
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.